Literature DB >> 7063282

A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants.

D A Ritter, J D Kenny, H J Norton, A J Rudolph.   

Abstract

To assess the value of free bilirubin (FB) measurements in predicting kernicterus (KI) in sick premature infants, 91 newborns weighing less than 1,500 gm at birth were observed during the first week of like with twice daily FB and total bilirubin determinations. Autopsies were performed on 30 of the 53 infants who died. Seven had KI and 23 did not. There were no differences between infants with and with out KI in the maximum FB level (KI 18.2 +/- 4.5 [SEM] nm/liter, no KI 11.1 +/- 0.9 nm/liter, P not significant) or the total bilirubin level (KI 7.3 +/- 1.3 mg/100 ml, no KI 6.1 +/- 0.5 mg/100 ml, P not significant). In fact, three kernicteric infants had very low maximum FB levels (less than 10 nm/liter). These three infants had prolonged episodes of acidosis, hypoxemia, or hypothermia during the 24 hours preceding their maximum level of FB. Although elevated levels of FB may be predictive of KI in some infants, other factors may make the blood-brain barrier more permeable to low levels of FB. This may limit the clinical applicability of FB measurements.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7063282

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  21 in total

Review 1.  The blood-brain barrier and bilirubin encephalopathy.

Authors:  R P Wennberg
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

2.  Assessment of neonatal jaundice in low birth weight infants comparing transcutaneous, capillary and arterial bilirubin levels.

Authors:  M Amato; P Huppi; D Markus
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

Review 3.  Is neonatal jaundice associated with Autism Spectrum Disorders: a systematic review.

Authors:  Sanjiv B Amin; Tristram Smith; Hongyue Wang
Journal:  J Autism Dev Disord       Date:  2011-11

Review 4.  The immunosuppressive effects of bilirubin.

Authors:  V Vĕtvicka; P Síma; I Miler; M Bilej
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

5.  Influence of intravenous fat emulsion on serum bilirubin in very low birthweight neonates.

Authors:  Y W Brans; D A Ritter; J D Kenny; D S Andrew; E B Dutton; D W Carrillo
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

6.  Skin colour and bilirubin in neonates.

Authors:  A Knudsen; R Brodersen
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

7.  Assessing the risk of kernicterus.

Authors:  H Nakamura
Journal:  Indian J Pediatr       Date:  1987 Sep-Oct       Impact factor: 1.967

Review 8.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

9.  Breast milk jaundice in premature infants.

Authors:  A Lucas; B A Baker
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

Review 10.  Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement.

Authors:  P C Walker
Journal:  Clin Pharmacokinet       Date:  1987-07       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.